Thursday, September 18, 2025 9/18/2025

Effect of weight loss on urinary oxalate excretion in obese calcium oxalate kidney stone formers

Award Number: R01DK128160
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2021
PERIOD OF PERFORMANCE END DATE: 03/31/2025

Group Awards By:

View Award Description

Effect of weight loss on urinary oxalate excretion in obese calcium oxalate kidney stone formers - SUMMARY The prevalence of kidney stone disease has dramatically increased in the United States (US) over the last 4 decades, now afflicting 8.8% of the population. Obesity which now affects over 40% of the US population is a recognized risk factor for the development of kidney stones. Calcium oxalate is the most common stone composition in the obese cohort. Urinary oxalate excretion significantly impacts the development of such stones and we and others have demonstrated that it is higher in obese kidney stone formers. Various factors can influence the amount of oxalate excreted in urine including the amount of oxalate consumed, its bio-availability, amount of dietary calcium, gastrointestinal and renal oxalate handling, and endogenous oxalate synthesis. We have found that obesity appears to increase endogenous oxalate synthesis. Others have reported that it disrupts the intestinal barrier which could result in augmented paracellular gut uptake. Obesity also appears to alter renal proximal tubular function. Thus, any one of these factors alone or in combination with the others could drive increased urinary oxalate excretion. The central hypothesis of this grant is that weight loss can reduce urinary oxalate excretion. While previous dietary approaches for kidney stone prevention have focused on macronutrients and micronutrients, caloric restriction has not been employed. We propose using an established and effective dietary weight reduction program, Optifast VLCD®, in obese, adult calcium oxalate stone formers and have crafted specific aims that focus on whether this will promote a reduction of the contribution of endogenous oxalate synthesis to the urinary oxalate pool, a decrease in gastrointestinal oxalate absorption and gut permeability, and/or alterations in renal oxalate handling. The proposed studies will be conducted in collaboration with experts in stone disease, metabolism, nutrition, endocrinology and weight loss at 2 large state institutions who provide care for this afflicted cohort. If the anticipated results of this feasibility study are achieved, this will serve as a strong platform to undertake a large clinical trial which could eventuate in an attenuation of stone disease as well as improvement or reversal of the many other co-morbidities associated with obesity.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	7/16/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $310,603 )
2023	2023	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	3/20/2023	NON-COMPETING CONTINUATION	$310,603
														Subtotal = $310,603

Issue Date FY: 2022 ( Subtotal = $310,603 )
2022	2022	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	3/30/2022	NON-COMPETING CONTINUATION	$310,603
														Subtotal = $310,603

Issue Date FY: 2021 ( Subtotal = $322,544 )
2021	2021	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	5/17/2021	NEW	$322,544
														Subtotal = $322,544

Grand Total All Awards = $943,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Effect of weight loss on urinary oxalate excretion in obese calcium oxalate kidney stone formers

Award Number: R01DK128160

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2021

PERIOD OF PERFORMANCE END DATE: 03/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer